NYSE
| Health Care |
Biotechnology
ADC Therapeutics SA (ADCT)
LAST (31 Mar)
MARKET CAP
VOLUME
| Open | 1.43 |
| Previous Close | 1.49 |
| Day Range | 1.28 - 1.46 |
| 52-Week Range | 1.28 - 5.38 |
| All-Time High | 56.59 |
| Avg. Volume (50-day) | 418,438.47 |
| EPS (TTM) | -1.66 |
| Next Earnings Date | 2025-05-05 (BMO) |
| Last Earnings Date | 2025-03-27 |
| Forward Annual Dividend (Yield) | - |
| Trailing Annual Dividend (Yield) | - |
| Options | Yes |
| P/E Ratio | -0.90 |
| PEG Ratio | - |
| Price to Book | -0.73 |
| Price to Cash Flow | - |
| Price to Free Cash Flow | - |
| Total Sales (TTM) | 70.84 M |
| Revenue per Share (TTM) | 0.67 |
| Shares Outstanding | 96.690 M |
| Share Float (%) | 77.81 M |
| % Held by Institutions | 56.72 |
| Dividends Per Share (TTM) | - |
| Ex-Dividend Date | - |
| +/- EMA(20) | 1.64 (-14.02%) |
| +/- SMA(50) | 1.66 (-15.06%) |
| +/- SMA(200) | 2.53 (-44.27%) |
| 5-Day Perf. | -14.55% |
| 1-Month Perf. | -19.89% |
| 3-Month Perf. | -29.15% |
| 6-Month Perf. | -55.31% |
| YTD Perf. | -29.15% |
| 1-Year Perf. | -68.6% |
| RSI(14) | 36.19 |
| ATR(14) | 0.13 |
| ADX(14) | 16.65 |
| Beta (5Y) | - |
FOR STOCKCHARTS MEMBERS ONLY
Unlock earnings and revenue history when you join StockCharts
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
ADCT
ADC Therapeutics SA
Sector: Health Care
Industry: Biotechnology
Employees: 265
Description
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
ADCT has triggered the following predefined scans:
| P&F Double Bottom Breakdown |
| Stocks in a New Downtrend (Aroon) |
| Moved Below Lower Price Channel |
| New 52-week Lows |
FOR STOCKCHARTS MEMBERS ONLY
Unlock custom technical alerts when you join StockCharts
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
FOR STOCKCHARTS MEMBERS ONLY
Unlock ChartLists to save and organize your charts when you join StockCharts
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.
